Bristol-Myers Squibb Company

II-ON Research Liaison, International Immuno-Oncology Network

Princeton, NJ, US
May 12, 2018
Required Education
Position Type
Full time

• The II-ON research liaison facilitates the establishment of research collaborations that detail the mechanistic properties of BMS assets and/or enhance the fundamental understanding immuno-oncology (I-O) science

• The research liaison leads project development and coordinates investigator activities across the network

• The research liaison ensures adequate bilateral scientific communication between BMS internal working groups, BMS functional and tumor-focused teams, and academic & institutional site members of II-ON


• With II-ON Core Team, lead II-ON investigator project strategy to ensure generation of high quality data and valuable impact on the I-O portfolio

• Serve as interface between network sites and BMS that properly connects investigators and internal teams.

• Actively engage member sites to foster network collaboration and investigator project development/execution

• Identify and prioritize project proposals for consideration by the Working Groups

• Directly interface with BMS researchers, tumor leads, OAR stakeholders and functional groups to ensure II-ON related projects and activities remain complimentary and strategically aligned to I-O strategy (e.g. member of ISR review committees, TR&D teams/sub teams)

• Exchange data and facilitate scientific discussions, externally and internally, to impact translational research decisions across I-O portfolio in all stages of development. Specifically, the research liaison plans and conducts data deep dives, investigator and BMS scientist working groups, congress investigator meetings, network site visits and yearly scientific symposiums

• Prepare and lead investigator project publication plan in coordination with Pub leads

• Responsible for providing project updates to oversight committee and senior management

• Attend appropriate I-O symposia and conferences both to represent BMS and to further enhance knowledge of current developments in I-O science and medicine


• PhD, MD, PharmD or equivalent in Oncology or Immunology-related field

• 5 or more years in pharmaceutical development

• Experience working with thought leaders and leading scientific collaborations is essential